Search PubMed⌕ Search

Biomedical subjects

R Manthorpe

Publications and source records attributed to R Manthorpe.

At least 127 records · Page 7Linked to original sources
PubMed1982

Tear absorption into the filter-paper strip used in the Schirmer-I-test. A methodological study and a critical survey.

The absorption of tear fluid into the Schirmer-I-filter paper was evaluated by serial measurements in 5 normal volunteers and in 32 patients with Sjögren's syndrome. The length of wetting was correlated to the weight of tear fluid absorbed in the paper strips. A linear relationship was demonstrated. We conclude that the Schirmer-I-test implies reproducible and fairly precise estimation of the tear flow even in cases of small lengths of wetting. The test is reliable, simple and useful for the diagnosis and follow-up of dry eyes, especially in patients with Sjögrens syndrome.

Absorption↗
PubMed1982

Cobalamin-binding proteins in serum and saliva from patients with Sjögren's syndrome.

Cobalamin-binding proteins in saliva and in serum were determined in 28 patients with primary Sjögren's syndrome (primary SS), 8 patients with secondary SS and 20 matched healthy controls. The unsaturated transcobalamin II level in serum was significantly increased in patients with secondary SS. The unsaturated cobalamin binding capacity in saliva was increased in patients with primary SS. Considerable interindividual variations were found between patients and in the control group. The local production of cobalamin-binding proteins in SS was sufficient to achieve concentrations in saliva comparable to the control group. The cobalamin-binding capacity in saliva was significantly correlated to the albumin concentration in both primary and secondary SS patients, suggesting a defect in the aqueous phase.

Adult↗
PubMed1982

Pulmonary function in patients with rheumatoid arthritis.

106 women and 38 men suffering from definite or classical rheumatoid arthritis underwent a pulmonary function test. The results were correlated to the duration and various clinical activity parameters of the disease. Pulmonary diffusion capacity was found to be reduced compared with the predicted values (p less than 0.05), irrespective of the duration or activity of the disease. The findings suggest that inflammatory vascular changes in the lungs usually occur in rheumatoid arthritis even in cases where other extraarticular manifestations can usually not be demonstrated.

Adolescent↗
PubMed1982

Fecal blood loss caused by two differently microencapsulated acetylsalicylic acid preparations in patients with rheumatoid arthritis. A prospective crossover study.

In an investigator-blind crossover study, fecal blood loss determined by 51Cr-labelled red cells was measured in 17 male patients with rheumatoid arthritis and one with anchylosing spondylitis. In two periods, each of one week's duration and separated by a 3-week wash-out period, the patients received microencapsulated acetylsalicylic acid (ASA) 3 g daily--either iwht time-dependent (Acetard) or with pH-depeendent release (Reumyl). With the exception of one patient, who suffered clinically significant bleeding, both preparations produced only moderate bleeding. The bleeding provoked by ASA with pH-dependent release (median blood loss in ml/day: first period 1.6; last period 2.6) was less than with time-dependent release (first period 1.8; last period 3.5).

Adult↗
PubMed1982

The biochemical properties of tendon and skin as influenced by long term glucocorticoid treatment and food restriction.

The influence of long term systemic glucocorticoid treatment and food restriction on the mechanical properties of muscle tendons and skin was investigated. A group of male, albino rabbits received prednisolone intramuscularly for 63 days. Another group was food restricted to achieve the same weight loss as the prednisolone treated group. The untreated control group had free access to food and water. Peroneus tertius and longus tendons and strip specimens of lumbal skin were tested in a materials testing machine. Long term prednisolone treatment reduced the dry weights of the muscle tendons, with no change in collagen content and "stress"-strain parameters. The elastic stiffness measured after exhaustion of the viscosity in the tendons was found to be increased. The collagen content of skin was reduced, which resulted in a weakening of the skin as such. However, the extensibility of the skin strips was reduced and the maximum "stress" value, i.e. load value normalized to collagen content, was increased. The food restriction did not change the mechanical properties of muscle tendons. For skin the collagen content was reduced and so were the maximum load and "stress" values after food restriction. It is concluded that both long term glucocorticoid treatment and food restriction reduce the amount of collagen and strength of skin, consistent with clinical experiences. However, in long term glucocorticoid treatment the remaining collagen has increased stability, probably caused by a changed cross-linking pattern, in contrast to a reduced stability of skin collagen in food restriction. Skin is thus influenced more easily than muscle tendon.

Animals↗
PubMed1981

Possible role of histamine in rheumatoid arthritis. Treatment with cimetidine and mepyramine.

Basophilocytes from patients with rheumatoid arthritis (RA) responded to leukocyte nuclei from normal persons with histamine release; a similar histamine release induced by the nuclear components RNA and DNA has been demonstrated previously. A role of histamine in RA is also supported by the findings of clinical improvement during treatment with H1 and H2 antihistamines in six of 12 patients with RA in active phase, whereas four showed definite deterioration.

Adolescent↗
PubMed1981

HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form.

HLA-A, B, C and D typing was performed in 19 patients with primary Sjögren's syndrome (primary SS) and in 15 patients with rheumatoid arthritis (RA) and secondary Sjögren's syndrome (RA-SS). In the primary SS group, the frequency of HLA-Dw2 was increased (p less than 0.01; "corrected" p greater than 0.05) while the frequency of Dw3 was non-significantly increased. In the RA-SS patients, the frequency of HLA-Dw4 was increased to 84.6% (relative risk = 22.8; p less than 0.001) and the frequency of Dw2 was non-significantly decreased. An increased frequency of Dw2 in primary SS has not been reported before. To investigate if this observation was due to chance, a new series of 16 patients with primary SS were HLA typed. In this new group, the frequencies of both Dw2 and Dw3 were significantly increased, while the frequency of Dw4 was significantly decreased. In the whole group of primary SS patients, the frequencies of Dw2 were 56.3% (relative risk = 3.7; p less than 0.001). Dw3:50.0% (relative risk = 2.8; p less than 0.01) and Dw4: 6.3% (relative risk = 0.28; p less than 0.05). We conclude that genetic factors associated with the HLA-system are involved in the development of Sjögren's syndrome and that these genetic factors are different in primary and secondary Sjögren's syndrome. In primary Sjögren's syndrome, the association with both Dw2 and Dw3 might suggest a further heterogeneity of the syndrome.

Arthritis, Rheumatoid↗
PubMed1981

Bromhexine treatment of Sjögren's syndrome: effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva.

In a randomized clinical study, 32 patients with Sögren's syndrome (SS were given placebo/bromhexine (Bisolvon) 48 mg daily for 3 weeks. Various ophthalmological and oral variables as well as different proteins in the tear fluid and saliva were registered. Bromhexine stimulated the tear secretion significantly, presumable without changing the protein composition of the tear fluid. In contrast to other proteins in saliva the IgM concentration decreased in patients with high pre-treatment values. Bromhexine may be of valuable help in the treatment of some patients with SS.

Adult↗
PubMed1981

Pseudothrombocytopenia. In vitro studies on the underlying mechanism.

In a prospective 9 month study at a medical department with special interest in immunology and rheumatology, 10 patients with spuriously low thrombocyte counts - pseudothrombocytopenia - were registered. The phenomenon was observed when the counting of platelets was performed on a Thrombocounter C apparatus or by manual counting using K2EDTA stabilized blood since platelet agglutination was considerably less pronounced when solution citratis glucosi fortis (ACD) was used as the anticoagulant. Results of our in vitro studies indicate that the mechanisms contributing to pseudothrombocytopenia involve the interaction of circulating immune complexes with platelet membrane Fc receptors causing agglutination. Fab'2-fragments of isolated patient IgG did not react with normal donor thrombocytes. This finding argues against agglutination due to true antiplatelet antibody activity.

Adult↗